Latest filing published 08 Feb 2010 for UNIGENE LABORATORIES INC.
Insider track record
No signal scores available.
Jay Levy: trading record in brief
Jay Levy discloses dealings in Unigene Laboratories Inc to SEC (Form 4). Over a trading history stretching from 15 March 2007 to 4 February 2010, the count stands at 8 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 8 February 2010 came the latest disclosure, a transaction in Unigene Laboratories Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jay Levy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 283,246 shares0Common Stock, $.01 par valueSEC:0001181431-10-007316:0
- 283,246 shares0Common Stock, $.01 par valueSEC:0001181431-10-007316:1
- 3,800 shares0Common Stock, $.01 par valueSEC:0001181431-10-003715:0
- 20,000 shares@ US$0.63Common Stock, $.01 par valueSEC:0001181431-09-048201:0
- 146,711 shares0Common Stock, $.01 par valueSEC:0001181431-08-018309:0
- 139,412 shares0Common Stock, $.01 par valueSEC:0001181431-08-018309:1
- 116,375 shares0Common Stock, $.01 par valueSEC:0001181431-07-020049:0
- 110,597 shares0Common Stock, $.01 par valueSEC:0001181431-07-020049:1
8 of 8 declarations
